Abbott Diabetes Care is a subsidiary of Abbott Laboratories, specializing in manufacturing and distributing medical devices, including blood glucose monitoring systems and related accessories, in the field of diabetes management.
Founded in 1888 by Dr. Wallace C. Abbott
Introduced innovative glucose monitoring technology in 1986
Acquired MediSense in 1996 and TheraSense in 2004, making it one of the largest providers of diabetes care products
Introduced the FreeStyle Libre Flash Glucose Monitoring System in 2014, revolutionizing diabetes management by allowing patients to continuously monitor their glucose levels without the need for finger-stick tests
Today, Abbott Diabetes Care serves customers in more than 150 countries.
Roche Diabetes Care is a division of Swiss healthcare company Roche, specializing in diabetes management products, including blood glucose monitoring systems, insulin pumps, and accessories.
Medtronic is a medical technology company that specializes in the development, manufacturing, and distribution of medical devices and therapies, including insulin pumps and continuous glucose monitoring systems for diabetes management.
Dexcom is a medical device company that specializes in continuous glucose monitoring systems for diabetes management.
A flash glucose monitoring system that allows patients to continuously monitor their glucose levels without the need for finger-stick tests.
An upgraded version of the FreeStyle Libre, featuring customizable alarms for high and low glucose readings.
The latest version of the FreeStyle Libre, featuring a slim and discreet sensor that can be worn for up to 14 days.
The FreeStyle Libre has a mean absolute difference (MAD) of 9.4 in adults and 9.1 in children, which exceeds the ISO accuracy standard of 20%. However, it is still important to calibrate the device with a finger-stick test occasionally.
The sensor for the FreeStyle Libre lasts for up to 14 days, after which it needs to be replaced with a new sensor.
Many insurance plans cover the FreeStyle Libre, but coverage varies by plan and location. Patients should consult with their insurance provider to determine their specific coverage and out-of-pocket costs.
The FreeStyle Libre does not require finger-stick tests for glucose monitoring, unlike other continuous glucose monitoring systems. Additionally, it is more affordable and easier to use, making diabetes management more accessible to patients.
The FreeStyle Libre software supports multiple languages, including English, Spanish, French, German, Italian, Dutch, and Portuguese.